Filtricine Analysis: $250K Raised
What is Filtricine?
Filtricine is a clinical-stage biotechnology company developing medical foods to manage cancer. Their lead product, Tality, is designed to deprive cancer cells of non-essential amino acids while providing essential nutrients. The company is based in the San Francisco Bay Area and is involved in clinical trials to validate its product's efficacy.
Location
440 N Wolfe Rd, Sunnyvale, California 94085, United States
Employees
1-10
Founded
2017
Funding Status
Seed
Product Features & Capabilities
- Tality meal replacement soups
- Tality meal replacement shakes
- Tality meal replacement bars
Use Cases
Prostate cancer patients participating in clinical trials; Cancer patients trying Tality for four weeks at no cost; Patients regaining control over their nutritional intake; Individuals seeking complete nutrition while undergoing cancer treatment; Participants experiencing decreased PSA levels during trials
Other Considerations
Sponsoring clinical trials at Stanford University; Early clinical study results show safety and nutritional completeness; Backed by venture capital in the San Francisco Bay Area
See something that needs updating? Suggest edits to this profile.